Alsulaimany M, El-Adl K, Aljohani A, Alharbi H, Alatawi O, Aljohani M
RSC Adv. 2023; 13(51):36301-36321.
PMID: 38093733
PMC: 10716637.
DOI: 10.1039/d3ra07700d.
Khodabakhsh F, Merikhian P, Eisavand M, Farahmand L
Cancer Cell Int. 2021; 21(1):200.
PMID: 33836774
PMC: 8033681.
DOI: 10.1186/s12935-021-01899-8.
Johnson M, Mowa C
Cell Tissue Res. 2021; 384(3):771-788.
PMID: 33511468
DOI: 10.1007/s00441-020-03354-y.
Park S, Jeong M, Ha K, Jang S
BMB Rep. 2018; 51(2):73-78.
PMID: 29397867
PMC: 5836560.
DOI: 10.5483/bmbrep.2018.51.2.233.
Subarnbhesaj A, Miyauchi M, Chanbora C, Mikuriya A, Nguyen P, Furusho H
PLoS One. 2017; 12(11):e0187092.
PMID: 29149180
PMC: 5693288.
DOI: 10.1371/journal.pone.0187092.
Activation of dengue virus-specific T cells modulates vascular endothelial growth factor receptor 2 expression.
Rattanamahaphoom J, Leaungwutiwong P, Limkittikul K, Kosoltanapiwat N, Srikaitkhachorn A
Asian Pac J Allergy Immunol. 2016; 35(3):171-178.
PMID: 27996292
PMC: 5529260.
DOI: 10.12932/AP0810.
PlGF-induced VEGFR1-dependent vascular remodeling determines opposing antitumor effects and drug resistance to Dll4-Notch inhibitors.
Iwamoto H, Zhang Y, Seki T, Yang Y, Nakamura M, Wang J
Sci Adv. 2015; 1(3):e1400244.
PMID: 26601163
PMC: 4640632.
DOI: 10.1126/sciadv.1400244.
Biomarkers of severe dengue disease - a review.
John D, Lin Y, Perng G
J Biomed Sci. 2015; 22:83.
PMID: 26462910
PMC: 4604634.
DOI: 10.1186/s12929-015-0191-6.
Intravitreal tanibirumab, a fully human monoclonal antibody against vascular endothelial growth factor receptor 2, partially suppresses and regresses laser-induced choroidal neovascularization in a rat model.
Kim J, Kim T, Kim J, Yun J, Sohn S, Shim S
J Ocul Pharmacol Ther. 2014; 30(10):847-53.
PMID: 25188901
PMC: 4259185.
DOI: 10.1089/jop.2014.0021.
The proliferation of malignant melanoma cells could be inhibited by ranibizumab via antagonizing VEGF through VEGFR1.
Li J, Cui Y, Wang Q, Guo D, Pan X, Wang X
Mol Vis. 2014; 20:649-60.
PMID: 24868139
PMC: 4021672.
Brain homeostasis: VEGF receptor 1 and 2-two unequal brothers in mind.
Wittko-Schneider I, Schneider F, Plate K
Cell Mol Life Sci. 2013; 70(10):1705-25.
PMID: 23475067
PMC: 3632714.
DOI: 10.1007/s00018-013-1279-3.
Vitreous mediators in retinal hypoxic diseases.
DellOmo R, Semeraro F, Bamonte G, Cifariello F, Romano M, Costagliola C
Mediators Inflamm. 2013; 2013:935301.
PMID: 23365490
PMC: 3556845.
DOI: 10.1155/2013/935301.
Post-transcriptional regulation of VEGF-A mRNA levels by mitogen-activated protein kinases (MAPKs) during metabolic stress associated with ischaemia/reperfusion.
Miller B, Hay J, Prigent S, Dickens M
Mol Cell Biochem. 2012; 367(1-2):31-42.
PMID: 22562302
DOI: 10.1007/s11010-012-1316-9.
Association of mast cell-derived VEGF and proteases in Dengue shock syndrome.
Furuta T, Murao L, Lan N, Huy N, Huong V, Thuy T
PLoS Negl Trop Dis. 2012; 6(2):e1505.
PMID: 22363824
PMC: 3283553.
DOI: 10.1371/journal.pntd.0001505.
Soluble VEGFR-2: an antilymphangiogenic variant of VEGF receptors.
Pavlakovic H, Becker J, Albuquerque R, Wilting J, Ambati J
Ann N Y Acad Sci. 2010; 1207 Suppl 1:E7-15.
PMID: 20961309
PMC: 3062194.
DOI: 10.1111/j.1749-6632.2010.05714.x.
Minireview: Won't get fooled again: the nonmetabolic roles of peroxisome proliferator-activated receptors (PPARs) in the heart.
Lockyer P, Schisler J, Patterson C, Willis M
Mol Endocrinol. 2009; 24(6):1111-9.
PMID: 20016041
PMC: 5417477.
DOI: 10.1210/me.2009-0374.
Vascular endothelial growth factor receptor-1 (VEGFR-1) expression in human corneal fibroblast decreased with age.
Berthaut A, Mirshahi P, Benabbou N, Azzazene D, Bordu C, Therwath A
Mol Vis. 2009; 15:1997-2007.
PMID: 19816604
PMC: 2756519.
Contribution of macrophages to angiogenesis induced by vascular endothelial growth factor receptor-3-specific ligands.
Chung E, Chauhan S, Jin Y, Nakao S, Hafezi-Moghadam A, van Rooijen N
Am J Pathol. 2009; 175(5):1984-92.
PMID: 19808642
PMC: 2774062.
DOI: 10.2353/ajpath.2009.080515.
Hypoxia-ischemia and retinal ganglion cell damage.
Kaur C, Foulds W, Ling E
Clin Ophthalmol. 2009; 2(4):879-89.
PMID: 19668442
PMC: 2699791.
DOI: 10.2147/opth.s3361.
Role of peroxisome proliferator-activated receptor alpha in the control of cyclooxygenase 2 and vascular endothelial growth factor: involvement in tumor growth.
Grau R, Diaz-Munoz M, Cacheiro-Llaguno C, Fresno M, Iniguez M
PPAR Res. 2008; 2008:352437.
PMID: 18670614
PMC: 2490577.
DOI: 10.1155/2008/352437.
